Skip to main content
Clinical Trials/IRCT20220119053760N2
IRCT20220119053760N2
Recruiting
Phase 2

A randomized Clinical trial to evaluate efficacy of intranasal Montelukast on the outcome of asthma attack in 2-12years old children

Esfahan University of Medical Sciences0 sites68 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Severe asthma attack.
Sponsor
Esfahan University of Medical Sciences
Enrollment
68
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children 2 to 12 years old
  • Hospitalization due to an acute asthma attack with a pulmonary index score (PIS) between 7 and 11 (moderate attack) or a score greater than 12 (severe attack)

Exclusion Criteria

  • Simultaneous treatment with systemic corticosteroids or antileukotrienes within 4 weeks before admission
  • Other possible causes for the patient's symptoms such as pneumonia
  • Having a history of chronic lung diseases and anatomical airway problems and congenital heart disease
  • History of taking anticonvulsant and immunosuppressive drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials